Tags: Drug.
Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2.This drug was developed by MedImmune LLC.
Loading...
This page contains content from the copyrighted Wikipedia article "Dusigitumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.